Northern Trust’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.7M Sell
519,412
-9,071
-2% -$202K ﹤0.01% 1987
2025
Q4
$13.7M Sell
528,483
-45,816
-8% -$1.09M ﹤0.01% 1920
2025
Q3
$14.8M Sell
574,299
-11,507
-2% -$283K ﹤0.01% 1885
2025
Q2
$14M Sell
585,806
-23,483
-4% -$592K ﹤0.01% 1871
2025
Q1
$15.1M Sell
609,289
-7,602
-1% -$182K ﹤0.01% 1797
2024
Q4
$11.6M Buy
616,891
+145,205
+31% +$2.55M ﹤0.01% 2042
2024
Q3
$7.1M Sell
471,686
-14,541
-3% -$249K ﹤0.01% 2268
2024
Q2
$13.9M Sell
486,227
-24,518
-5% -$698K ﹤0.01% 1796
2024
Q1
$14.9M Sell
510,745
-17,516
-3% -$538K ﹤0.01% 1801
2023
Q4
$17.8M Buy
528,261
+24,599
+5% +$720K ﹤0.01% 1695
2023
Q3
$15.5M Buy
503,662
+3,325
+0.7% +$120K ﹤0.01% 1720
2023
Q2
$20M Sell
500,337
-10,076
-2% -$417K ﹤0.01% 1583
2023
Q1
$20.8M Buy
510,413
+4,648
+0.9% +$185K ﹤0.01% 1522
2022
Q4
$19.5M Buy
505,765
+13,561
+3% +$660K ﹤0.01% 1540
2022
Q3
$26.2M Buy
492,204
+1,413
+0.3% +$78.6K 0.01% 1288
2022
Q2
$28.6M Sell
490,791
-7,504
-2% -$492K 0.01% 1293
2022
Q1
$38M Sell
498,295
-11,647
-2% -$776K 0.01% 1222
2021
Q4
$30.7M Sell
509,942
-12,404
-2% -$684K 0.01% 1473
2021
Q3
$29.3M Sell
522,346
-5,199
-1% -$300K 0.01% 1503
2021
Q2
$32M Sell
527,545
-3,164
-0.6% -$200K 0.01% 1542
2021
Q1
$37.2M Sell
530,709
-26,250
-5% -$1.88M 0.01% 1354
2020
Q4
$33.3M Sell
556,959
-11,873
-2% -$695K 0.01% 1401
2020
Q3
$34.2M Sell
568,832
-24,599
-4% -$1.43M 0.01% 1192
2020
Q2
$31.1M Buy
593,431
+36,974
+7% +$1.55M 0.01% 1270
2020
Q1
$18.7M Buy
556,457
+8,274
+2% +$344K 0.01% 1450
2019
Q4
$24.8M Sell
548,183
-24,475
-4% -$1.04M 0.01% 1566
2019
Q3
$21.8M Buy
572,658
+49,055
+9% +$1.96M 0.01% 1622
2019
Q2
$22.8M Buy
523,603
+1,200
+0.2% +$50.9K 0.01% 1595
2019
Q1
$19.9M Buy
522,403
+2,466
+0.5% +$96.2K ﹤0.01% 1692
2018
Q4
$22.4M Sell
519,937
-2,078
-0.4% -$97K 0.01% 1484
2018
Q3
$25.7M Buy
522,015
+9,933
+2% +$429K 0.01% 1586
2018
Q2
$16.4M Buy
512,082
+20,877
+4% +$721K ﹤0.01% 1923
2018
Q1
$15.3M Buy
491,205
+1,452
+0.3% +$51.7K ﹤0.01% 1890
2017
Q4
$22.4M Sell
489,753
-8,885
-2% -$352K 0.01% 1622
2017
Q3
$18.7M Sell
498,638
-6,891
-1% -$277K ﹤0.01% 1760
2017
Q2
$24.1M Buy
505,529
+42,289
+9% +$1.96M 0.01% 1531
2017
Q1
$21.1M Buy
463,240
+3,936
+0.9% +$170K 0.01% 1607
2016
Q4
$14.8M Sell
459,304
-16,345
-3% -$545K ﹤0.01% 1824
2016
Q3
$16.3M Sell
475,649
-3,456
-0.7% -$135K 0.01% 1735
2016
Q2
$16.2M Sell
479,105
-14,384
-3% -$707K 0.01% 1693
2016
Q1
$25.5M Sell
493,489
-49,413
-9% -$2.89M 0.01% 1305
2015
Q4
$41.7M Buy
542,902
+38,215
+8% +$2.16M 0.01% 932
2015
Q3
$20.7M Sell
504,687
-4,272
-0.8% -$262K 0.01% 1470
2015
Q2
$36M Buy
508,959
+40,506
+9% +$3.19M 0.01% 1108
2015
Q1
$41.6M Sell
468,453
-527
-0.1% -$53.5K 0.01% 1011
2014
Q4
$41.6M Sell
468,980
-6,301
-1% -$596K 0.01% 968
2014
Q3
$46.1M Buy
475,281
+90,206
+23% +$8.78M 0.01% 850
2014
Q2
$35.4M Sell
385,075
-9,414
-2% -$717K 0.01% 1061
2014
Q1
$27.6M Sell
394,489
-15,194
-4% -$1.03M 0.01% 1297
2013
Q4
$23.6M Buy
409,683
+9,815
+2% +$516K 0.01% 1389
2013
Q3
$19.2M Buy
399,868
+92,128
+30% +$3.36M 0.01% 1487
2013
Q2
$8.93M Buy
+307,740
New +$8.9M ﹤0.01% 2006

Other funds holding PCRX